What is Panacea Life Sciences Holdings Scaled Net Operating Assets?
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Panacea Life Sciences Holdings's operating assets for the quarter that ended in Jun. 2024 was $16.81 Mil. Panacea Life Sciences Holdings's operating liabilities for the quarter that ended in Jun. 2024 was $5.81 Mil. Panacea Life Sciences Holdings's Total Assets for the quarter that ended in Mar. 2024 was $17.41 Mil. Therefore, Panacea Life Sciences Holdings's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.63.
Panacea Life Sciences Holdings Scaled Net Operating Assets Historical Data
The historical data trend for Panacea Life Sciences Holdings's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings Scaled Net Operating Assets Chart
|
Panacea Life Sciences Holdings Annual Data
|
|
Trend |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Scaled Net Operating Assets |
|
0.85 |
0.58 |
0.66 |
0.68 |
|
Panacea Life Sciences Holdings Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
| Scaled Net Operating Assets |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
0.74 |
0.80 |
0.71 |
0.67 |
0.63 |
Competitive Comparison of Panacea Life Sciences Holdings's Scaled Net Operating Assets
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's Scaled Net Operating Assets falls into.
Panacea Life Sciences Holdings Scaled Net Operating Assets Calculation
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Panacea Life Sciences Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as
| Scaled Net Operating Assets (SNOA) | | (A: Dec. 2023 ) |
| = | (Operating Assets (A: Dec. 2023 ) | - | Operating Liabilities (A: Dec. 2023 )) | / | Total Assets (A: Dec. 2022 ) |
| = | (17.867 | - | 4.63) | / | 19.489 |
| = | 0.68 |
where
Panacea Life Sciences Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as
| Scaled Net Operating Assets (SNOA) | | (Q: Jun. 2024 ) |
| = | (Operating Assets (Q: Jun. 2024 ) | - | Operating Liabilities (Q: Jun. 2024 )) | / | Total Assets (Q: Mar. 2024 ) |
| = | (16.807 | - | 5.805) | / | 17.413 |
| = | 0.63 |
where
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings Business Description
Traded in Other Exchanges
N/A
Address
5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.
Executives
| Leslie Buttorff |
director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| Janice Nerger |
director |
5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121 |
| Nathan Joel Berman |
officer: CONTROLLER & PRIN ACTNG OFCR |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| 22nd Century Group, Inc. |
10 percent owner |
8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221 |
| Harvey J Kesner |
10 percent owner |
65 E. 55TH STREET, NEW YORK NY 10022 |
| Lawrence Wert |
director |
170 NUTTALL RD, RIVERSIDE IL 60546 |
| Chesne Derek Du |
officer: Chief Growth Officer |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Alvaro Daniel Alberttis |
director |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Vladislav Yampolsky |
director, 10 percent owner |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Steven A Schwartz |
director |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Andrew L. Johnson |
officer: Chief Strategy Officer |
80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483 |
| Emiliano Angel Aloi |
officer: President |
510 SUNSHINE DRIVE, DELRAY BEACH FL 33444 |
| Jonathan Gilbert |
director, officer: Executive Chairman |
36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577 |
| John C Price |
director |
4721 IRONTON STREET, BUILDING A, DENVER CO 80239 |
| Kevin James Esval |
director |
NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019 |
Panacea Life Sciences Holdings Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLSH has been successfully added to your